Raser Technologies, Inc. Patents Advanced Electric Motor Technology; U.S. Patent and Trademark Office Awards Raser Patent for its Symetron Motor Technology

Business Wire, Jan 25, 2005

PROVO, Utah -- Raser Technologies, Inc. (OTCBB:RSTG), a technology licensing company established to develop and license advanced electric motor, controller and related technologies, was notified today by the United States Patent and Trademark Office of the issuance of Raser's first U.S. Patent.

The issued patent covers some of the initial electric motor concepts of Raser's Symetron(TM) technologies. Raser has also filed applications for several patents in the areas of advanced alternator and generator technologies.

"Issuance of our initial advanced motor technology patent is an important first step in highlighting the uniqueness of our electric motor technology. This patent serves as one keystone upon which several subsequent patents have been filed," said Raser CEO, Kraig Higginson. "We will continue to actively develop our intellectual property portfolio of technologies consistent with our strategy. We believe our technologies will address the needs of our customers and assist them in providing a significant enhancement to existing product lines," stated Mr. Higginson.

About Raser Technologies

Founded in 2001, Raser Technologies believes that its pending patents and proprietary intellectual property cover breakthrough technologies. Raser's Symetron(TM) technologies more efficiently harness's electrical energy in electric motors, controllers, alternator and generator technologies. Application of Symetron(TM) generally requires simple changes to existing products, but yields significant increases in power, performance and efficiency without the use of exotic materials. Further information on Raser Technologies, Inc. may be found at: www.rasertech.com.

Cautionary Note Regarding Forward-Looking Statements

This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including, but not limited to, statements regarding the Company's beliefs about the Symetron(TM) technology, the allocation of capital and the company's commitment to the development and testing of the Symetron(TM) technologies, its applications, performance characteristics and the business prospects for such technology and the Company, and the Company's future results of operations. These forward-looking statements involve certain risks and uncertainties that could cause actual results to differ, including, without limitation, our limited operating history and history of losses, our inability to successfully license our technology, our inability to successfully obtain research and development funding opportunities from military and government programs, our inability to raise capital on terms acceptable to us, our inability to achieve listing on a national stock exchange, our inability to achieve commercial acceptance of our technology, our inability to compete effectively in the marketplace, our inability to improve or implement effective systems, procedures and controls, the strength of our patents and other intellectual property, our inability to protect our intellectual property, our inability to attract, train and retain key personnel, and such other risks as identified in our quarterly report on Form 10-QSB for the period ended September 30, 2004, as filed with the Securities and Exchange Commission, and all subsequent filings, which contain and identify important factors that could cause the actual results to differ materially from those contained in our projections or forward-looking statements. All forward-looking statements in this press release are based on information available to us as of the date hereof, and we undertake no obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this press release.